Literature DB >> 7212510

Computed tomography brain scanning in alcohol withdrawal seizures. Value of the neurologic examination.

J R Feussner, E W Linfors, C L Blessing, C F Starmer.   

Abstract

We evaluated the usefulness of computed tomography (CT) brain scanning in alcoholic patients with withdrawal seizures (n = 151) and other neurologic problems (n = 87) and compared the findings of a detailed neurologic examination to the results of CT scanning. In patients with seizures, nearly 50% of CT scans were normal, 34% showed generalized cerebral atrophy, and only 15% showed focal structural lesions. When focal neurologic deficits were present, 30% of CT scans showed focal structural lesions compared to 6% when such deficits were absent (p less than 0.0002). The frequency of potentially reversible lesions was 18% in patients with and 1% in patients without focal neurologic deficits (p less than 0.0002). Of patients treated surgically, 9% had focal neurologic deficits and 1% did not (p less than 0.03). Results were similar in alcoholic patients with other neurologic problems. Careful use of the neurologic examination adequately determines which patients need prompt CT scanning. In the absence of either focal deficits on neurologic examination or signs of acute head trauma, CT brain scanning does not improve the evaluation of patients with alcohol withdrawal seizures.

Entities:  

Mesh:

Year:  1981        PMID: 7212510     DOI: 10.7326/0003-4819-94-4-519

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

Review 1.  Physical diagnosis versus modern technology. A review.

Authors:  F T Fitzgerald
Journal:  West J Med       Date:  1990-04

2.  Indication for computed tomography of the brain in patients with first uncomplicated generalised seizure.

Authors:  R A Schoenenberger; S M Heim
Journal:  BMJ       Date:  1994-10-15

3.  Yield of Emergent CT in Patients With Epilepsy Presenting With a Seizure.

Authors:  Kathryn A Kvam; Vanja C Douglas; William D Whetstone; S Andrew Josephson; John P Betjemann
Journal:  Neurohospitalist       Date:  2018-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.